Azelead works on therapeutic fields such as:
Oncology, infection, neurological disorders, toxicity, ecotoxicology and rare diseases.

Oncology

— ONCO-Platform
— Xenotransplantation models
— Metastasis model
— High content screening

MORE DETAILS
infection

Infection

— Infection models (P1 / P2 / P3)
(in collaboration with Cemipai)
— Real-time imaging
(immune and pathogenic cells)
— High content screening

MORE DETAILS

Neurological Disorders

— Blood-brain barrier
— Microglia
— Behavioral analysis
— Neurotoxic

MORE DETAILS
Toxicity-2

Toxicity

Acute toxicity

Nervous System Development
— Cardiac development
(in collaboration with Physiostyme)
— Hematopoiesis and vessel development
— Ototoxicity
(in collaboration with CILcare)

ecotoxicology-2

Ecotoxicology

FET OCDE 236

— Embryo survival
— Coagulation of fertilized eggs
— Failure to form somites
— Failure to detach the tail bud
— Heartbeat failure
— LC50

rare-diseases

Rare diseases

— Edition
— Transgenesis
— Inactivation of genes
— Characterization